WallStreetZenWallStreetZen

NASDAQ: OCX
Oncocyte Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Oncocyte revenue was $1.88M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $1.5M, up 1,192.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, OCX annual revenue was $1.9M, with 25.1% growth year-over-year.

OCX past revenue growth

How has OCX's revenue growth performed historically?

Company
25.15%
Industry
3.84%
Market
20.68%
OCX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
OCX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
OCX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

OCX revenue history

Current Revenue
$1.9M
Current Earnings
-$60.9M
Current Profit Margin
-3,239%

Be the first to know when OCX announces revenue.

OCX Revenue History By Year

OCX Yearly RevenueOCX RevenueOCX ChangeOCX Revenue Growth
2024-12-31$1.88M$378.00k+25.15%
2023-12-31$1.50M$545.00k+56.89%
2022-12-31$958.00k-$1.24M-56.41%
2021-12-31$2.20M$982.00k+80.76%
2020-12-31$1.22MN/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00N/AN/A
2013-12-31$0.00N/AN/A

1 of 1

Oncocyte Revenue FAQ

What was OCX's revenue last quarter?

Oncocyte (NASDAQ: OCX) reported Q4 2024 revenue of $1.49 million up 373.25% year over year. In the same quarter last year, Oncocyte's revenue was $314.00 thousand.

What was Oncocyte's revenue in 2024?

Oncocyte's annual revenue for the twelve months ending Dec 31, 2024 was $1.88 million, a 25.15% increase year over year.

How much does Oncocyte make in a day?

Based on Oncocyte annual revenue for the past five years, OCX makes an average of $4,249.86 per day.

What was Oncocyte's annual revenue growth in the past year?

As of Q2 2025, Oncocyte's revenue has grown 25.15% year over year. This is 21.31 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 3.84%. Oncocyte's revenue in the past year totaled $1.88 million.

How much does Oncocyte make in a year?

Oncocyte's revenue by year for the past five years is:
  • Oncocyte's revenue for the twelve months ending Dec 31, 2024 was $1.88 million, a 25.15% increase year over year.
  • Oncocyte's annual revenue for Dec 31, 2023 was $1.50 million, a 56.89% increase from 2022.
  • Oncocyte's annual revenue for 2022 was $958.00 thousand, a 56.41% decrease from 2021.
  • Oncocyte's annual revenue for 2021 was $2.20 million, a 80.76% increase from 2020.
  • Oncocyte's annual revenue for 2020 was $1.22 million, a Infinity% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.